[1] Francesmonneris A,Pincus H,First M. Diagnostic and statistical manual of mental disorders:DSM-V[M]. Washington DC:American Psychiatric Association,2013. [2] Maenner MJ,Shaw KA,Baio J,et al.Prevalence of autism spectrum disorder among children aged 8 years-autism and developmental disabilities monitoring network,11 sites,United States,2016[J].MMWR Surveill Summ,2020,69(4):1-12. [3] Jacome MCI,Chacon LMM,Cuesta HV,et al.Peripheral inflammatory markers contributing to comorbidities in autism[J].Behav Sci (Basel),2016,6(4):29. [4] Li X,Chauhan A,Sheikh AM,et al.Elevated immune response in the brain of autistic patients[J].J Neuroimmunol,2009,207(1-2):111-116. [5] Nomura DK,Morrison BE,Blankman JL,et al.Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation[J].Science,2011,334(6057):809-813. [6] Rahmani MR,Shamsizadeh A,Moghadam-Ahmadi A,et al.JZL184,as a monoacylglycerol lipase inhibitor,down-regulates inflammation in a cannabinoid pathway dependent manner[J].Biomed Pharmacother,2018,103:1720-1726. [7] 李德欣. eCB系统异常与ASD儿童认知及社交功能的相关性研究 [D]. 哈尔滨:哈尔滨医科大学,2020. [8] 李玲. VPA诱导的孤独症模型鼠中内源性大麻素系统表达的差异研究[D]. 哈尔滨:哈尔滨医科大学,2020. [9] Blankman JL,Simon GM,Cravatt BF. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol[J].Chem Biol,2007,14(12):1347-1356. [10] Hu CC,Xu X,Xiong GL,et al.Alterations in plasma cytokine levels in chinese children with autism spectrum disorder[J].Autism Res,2018,11(7):989-999. [11] Xie J,Huang L,Li X,et al.Immunological cytokine profiling identifies TNF-alpha as a key molecule dysregulated in autistic children[J].Oncotarget,2017,8(47):82390-82398. [12] Eissa N,Azimullah S,Jayaprakash P,et al.The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice[J].Chem Biol Interact,2019,312:108775. [13] Ahmad SF,Nadeem A,Ansari MA,et al.The potent immunomodulatory compound VGX-1027 regulates inflammatory mediators in CD4(+) T cells,which are concomitant with the prevention of neuroimmune dysregulation in BTBR T(+) Itpr3(tf)/J mice[J].Life Sci,2019,237:116930. [14] Habib SS,Al-Regaiey K,Bashir S,et al.Role of endocannabinoids on neuroinflammation in autism spectrum disorder prevention[J].J Clin Diagn Res,2017,11(6):Ce1-ce3. [15] Wilson RI,Nicoll RA. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses[J].Nature,2001,410(6828):588-592. [16] Zamberletti E,Gabaglio M,Parolaro D. The endocannabinoid system and autism spectrum disorders:Insights from animal models[J].Int J Mol Sci,2017,18(9):1916. [17] Mecha M,Feliú A,Machín I,et al.2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs[J].Glia,2018,66(7):1447-1463. |